Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice

Cancer Research

Volumn 70, Issue 16, 2010, Pages 6427-6436

  Yasui, Hironobu ^a   Matsumoto, Shingo ^a   Devasahayam, Nallathamby ^a   Munasinghe, Jeeva P ^b   Choudhuri, Rajani ^a   Saito, Keita ^a   Subramanian, Sankaran ^a   Mitchell, James B ^a   Krishna, Murali C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGEN TENSION; BREATHING; CELL DENSITY; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICYTE; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TUMOR VOLUME; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; C3H MOUSE; CANCER TRANSPLANTATION; CELL HYPOXIA; COLON TUMOR; FEMALE; HT 29 CELL LINE; HUMAN; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PRESSURE; PROCEDURES; SQUAMOUS CELL CARCINOMA; VASCULARIZATION; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; COLONIC NEOPLASMS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C3H; MICE, NUDE; NEOPLASM TRANSPLANTATION; OXYGEN; PARTIAL PRESSURE; TRANSPLANTATION, HETEROLOGOUS;

OXYGEN;

EID: 77955761645     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1350     Document Type: Article

References (50)

1. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007;6:273-86.
2. Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res 2007;74:72-84. (Pubitemid 350051025)
3. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987;6:559-93.
4. 2 gradients in window chamber tumours: impact on tumour hypoxia. Br J Cancer 1999;79:1717-22.
5. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-49.
6. Powers WE, Tolmach LJ. A multicomponent x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature 1963;197:710-1.
7. Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988;14:831-8.
8. Hockel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15.
9. Brizel DM, Dodge RK, Clough RW, Dewhirst MW. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-7.
10. Dewhirst MW. Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress. Radiat Res 2009;172:653-65.
11. Brown JM. The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 1999;59:5863-70.
12. Brown JM. Hypoxic cytotoxic agents: a new approach to cancer chemotherapy. Drug Resist Updat 2000;3:7-13.
13. Chaplin DJ, Olive PL, Durand RE. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 1987;47:597-601.
14. Kimura H, Braun RD, Ong ET, et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 1996;56:5522-8.
15. Cairns RA, Kalliomaki T, Hill RP. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 2001;61:8903-8.
16. Cairns RA, Hill RP. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 2004;64:2054-61.
17. Cairns RA, Khokha R, Hill RP. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 2003;3:659-71.
18. Chaplin DJ, Trotter MJ, Durand RE, Olive PL, Minchinton AI. Evidence for intermittent radiobiological hypoxia in experimental tumour systems. Biomed Biochim Acta 1989;48:S255-9.
19. Bennewith KL, Durand RE. Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Res 2004;64:6183-9.
20. Braun RD, Lanzen JL, Dewhirst MW. Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Am J Physiol 1999;277:H551-68.
21. Baudelet C, Ansiaux R, Jordan BF, et al. Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia? Phys Med Biol 2004;49:3389-411.
22. Baudelet C, Cron GO, Ansiaux R, et al. The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors. NMR Biomed 2006;19:69-76.
23. 2 in irradiated human melanoma xenografts. Radiat Res 2006;165:16-25.
24. Wang K, Yorke E, Nehmeh SA, Humm JL, Ling CC. Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET. Med Phys 2009;36:4400-8.
25. Goda F, Bacic G, O'Hara JA, et al. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. Cancer Res 1996;56:3344-9.
26. Goda F, O'Hara JA, Rhodes ES, et al. Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation. Cancer Res 1995;55:2249-52.
27. Elas M, Bell R, Hleihel D, et al. Electron paramagnetic resonance oxygen image hypoxic fraction plus radiation dose strongly correlates with tumor cure in FSa fibrosarcomas. Int J Radiat Oncol Biol Phys 2008;71:542-9.
28. Ansiaux R, Baudelet C, Jordan BF, et al. Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res 2005;11:743-50.
29. Jordan BF, Gregoire V, Demeure RJ, et al. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res 2002;62:3555-61.
30. Ardenkjaer-Larsen JH, Laursen I, Leunbach I, et al. EPR and DNP properties of certain novel single electron contrast agents intended for oximetric imaging. J Magn Reson 1998;133:1-12.
31. Elas M, Williams BB, Parasca A, et al. Quantitative tumor oxymetric images from 4D electron paramagnetic resonance imaging (EPRI): methodology and comparison with blood oxygen level-dependent (BOLD) MRI. Magn Reson Med 2003;49:682-91.
32. 2 determination. Magn Reson Med 2006;55:1157-63.
33. Elas M, Ahn KH, Parasca A, et al. Electron paramagnetic resonance oxygen images correlate spatially and quantitatively with Oxylite oxygen measurements. Clin Cancer Res 2006;12:4209-17.
34. Lai CS, Hopwood LE, Hyde JS, Lukiewicz S. ESR studies of O2 uptake by Chinese hamster ovary cells during the cell cycle. Proc Natl Acad Sci U S A 1982;79:1166-70.
35. Matsumoto S, Hyodo F, Subramanian S, et al. Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice. J Clin Invest 2008;118:1965-73.
36. Devasahayam N, Subramanian S, Murugesan R, et al. Strategies for improved temporal and spectral resolution in in vivo oximetric imaging using time-domain EPR. Magn Reson Med 2007;57:776-83.
37. Dharmaraj CD, Thadikonda K, Fletcher AR, et al. Reconstruction for time-domain in vivo EPR three-dimensional multigradient oximetric imaging-a parallel processing perspective. Int J Biomed Imaging 2009;2009:528639.
38. Subramanian S, Devasahayam N, Murugesan R, et al. Single-point (constant-time) imaging in radiofrequency Fourier transform electron paramagnetic resonance. Magn Reson Med 2002;48:370-9.
39. Devasahayam N, Subramanian S, Murugesan R, et al. Parallel coil resonators for time-domain radiofrequency electron paramagnetic resonance imaging of biological objects. J Magn Reson 2000;142:168-76.
40. Hyodo F, Matsumoto S, Devasahayam N, et al. Pulsed EPR imaging of nitroxides in mice. J Magn Reson 2009;197:181-5.
41. Matsumoto K, English S, Yoo J, et al. Pharmacokinetics of a triarylmethyl-type paramagnetic spin probe used in EPR oximetry. Magn Reson Med 2004;52:885-92.
42. Hyodo F, Chandramouli GV, Matsumoto S, et al. Estimation of tumor microvessel density by MRI using a blood pool contrast agent. Int J Oncol 2009;35:797-804.
43. Azuma C, Raleigh JA, Thrall DE. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiat Res 1997;148:35-42.
44. Matsumoto S, Yasui H, Batra S, et al. Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI. Proc Natl Acad Sci U S A 2009;106:17898-903.
45. Zhou Q, Guo P, Gallo JM. Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. Clin Cancer Res 2008;14:1540-9.
46. ImageJ: Image processing and analysis in Java. Available from: http://rsb.info.nih.gov/ij/.
47. Hendriksen EM, Span PN, Schuuring J, et al. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Microvasc Res 2009;77:96-103.
48. Sorg BS, Moeller BJ, Donovan O, Cao Y, Dewhirst MW. Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. J Biomed Opt 2005;10:44004.
49. Lin Z, Mechalakos J, Nehmeh S, et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 2008;70:1219-28.
50. Leibel SA, Fuks Z, Zelefsky MJ, et al. Intensity-modulated radiotherapy. Cancer J 2002;8:164-76.